Free Trial
OTCMKTS:ECTE

Echo Therapeutics (ECTE) Stock Price, News & Analysis

Echo Therapeutics logo
$0.0002 0.00 (0.00%)
As of 09/7/2021

About Echo Therapeutics Stock (OTCMKTS:ECTE)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
$0.28
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ.

Receive ECTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Echo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ECTE Stock News Headlines

ECTE/BTC - EurocoinToken Bitcoin
What are echo chambers?
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
ECTE/USD Synthetic Historical Data
ECTE Historical Data
See More Headlines

ECTE Stock Analysis - Frequently Asked Questions

Echo Therapeutics' stock was trading at $0.0002 at the beginning of the year. Since then, ECTE stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2025 here
.

Echo Therapeutics, Inc. (OTCMKTS:ECTE) announced its quarterly earnings data on Friday, August, 12th. The medical device company reported ($0.82) EPS for the quarter.

Shares of ECTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Echo Therapeutics investors own include DexCom (DXCM), Rexahn Pharmaceuticals (REXN), Acer Therapeutics (ACER), Athersys (ATHX), Blackstone Strategic Credit 2027 Term Fund (BGB), Biocept (BIOC) and BlackRock Science and Technology Trust (BST).

Company Calendar

Last Earnings
8/12/2016
Today
5/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:ECTE
Previous Symbol
NASDAQ:ECTE
Employees
19
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:ECTE) was last updated on 5/16/2025 by MarketBeat.com Staff
From Our Partners